Lisinopril HCTZ

Awarded Award Notice Posted

Solicitation number
SPE2D2-23-D-0005
Agency
Medical Supply Chain Troop Support, Department of Defense
Awarded
to Exelan Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D2-23-D-0005 Federal IDV award
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Place of performance
Hauppauge, New York 11788, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical awarded Exelan Pharmaceuticals Inc. contract SPE2D2-23-D-0005 on February 1, 2022 for the supply of various strengths and package sizes of lisinopril HCTZ tablets, used to treat high blood pressure, with a total estimated value of $28,235,184.10 over five years or approximately $5,647,036.82 per year. Exelan Pharmaceuticals will manufacture the products at its facility in Hauppauge, New York and package, pack, and prepare them for shipment from its facility in Central Islip, New York through five option years extending to 2027.

Notice text

NATIONAL CONTRACT SPE2D223D0005 LISINOPRIL HCTZ TABLETS

Awarded contract SPE2D2-23-D-0005 to EXELAN PHARMACEUTICALS INC for 28235184.10 on 2022-02-01.

Attachments

Files attached to this notice, newest first
File Type Posted
SF30_SPE2D223D0005P00003 Signed.PDF PDF
Signed SPE2D223D0005 P00002.pdf PDF
Bilaterally Signed Lisinopril HCTZ Award SPE2D223D0005.pdf PDF

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Lisinopril HCTZ This notice · Award Award Notice
Lisinopril HCTZ Latest solicitation Solicitation
Lisinopril HCTZ Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity